Tissium SA
Valquest co-invested in Tissium SA a European Biotech company that has developed an innovative polymer solution set to revolutionize a broad range of surgical procedures.
Valquest is leveraging its network to help Tissium expand its root to market in select MENA and Indian subcontinent markets.
Valquest is at a stage to accompany n the resource deployment for the launch of Tissium first therapeuticalapplication in the US market.